ARB is showing a rare alignment across all timeframes:
🔹 5m – 15m: Short-term structure consolidating right below a 0.348 liquidity shelf, with multiple small FVGs suggesting a coiled breakout zone.
🔹 30m – 1h: Mid-range compression between 0.334 – 0.348; price continues to defend the 200 EMA and is building higher-low structure.
🔹 1W (Weekly): A clean bullish FVG has formed—if price fills and reclaims this zone, it could unlock nearly 100 % upside potential from current levels.
🔹 1M (Monthly): Macro support sits around 0.32 – 0.34, marking the accumulation floor since early 2024.
Together, these setups hint that ARB may be preparing for a strong rotation phase once market liquidity returns.
📈 Key Levels:
Support → 0.334 / 0.321
Resistance → 0.348 / 0.36
Macro Target (Weekly FVG Top) → ≈ 0.60 region
💡 Observation: Watch how USDT Dominance behaves around 4.82 %. A rejection there could trigger ARB’s next leg up.
🔹 5m – 15m: Short-term structure consolidating right below a 0.348 liquidity shelf, with multiple small FVGs suggesting a coiled breakout zone.
🔹 30m – 1h: Mid-range compression between 0.334 – 0.348; price continues to defend the 200 EMA and is building higher-low structure.
🔹 1W (Weekly): A clean bullish FVG has formed—if price fills and reclaims this zone, it could unlock nearly 100 % upside potential from current levels.
🔹 1M (Monthly): Macro support sits around 0.32 – 0.34, marking the accumulation floor since early 2024.
Together, these setups hint that ARB may be preparing for a strong rotation phase once market liquidity returns.
📈 Key Levels:
Support → 0.334 / 0.321
Resistance → 0.348 / 0.36
Macro Target (Weekly FVG Top) → ≈ 0.60 region
💡 Observation: Watch how USDT Dominance behaves around 4.82 %. A rejection there could trigger ARB’s next leg up.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.